Terveystalo Oyj
Market Cap
€1.3b
Last Updated
2021/01/22 18:43 UTC
Data Sources
Company Financials +
Executive Summary
Terveystalo Oyj provides occupational healthcare services in Finland. More Details
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has Terveystalo Oyj's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TTALO is less volatile than 75% of Finnish stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: TTALO's weekly volatility (3%) has been stable over the past year.
Market Performance
7 Day Return
1.9%
TTALO
-0.03%
FI Healthcare
1.4%
FI Market
1 Year Return
-15.0%
TTALO
-4.5%
FI Healthcare
9.7%
FI Market
Return vs Industry: TTALO underperformed the Finnish Healthcare industry which returned -4.7% over the past year.
Return vs Market: TTALO underperformed the Finnish Market which returned 8.6% over the past year.
Shareholder returns
| TTALO | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.9% | -0.03% | 1.4% |
| 30 Day | 5.0% | 2.9% | 6.7% |
| 90 Day | 5.6% | 8.1% | 12.0% |
| 1 Year | -13.8%-15.0% | -2.9%-4.5% | 19.0%9.7% |
| 3 Year | 9.0%4.5% | -12.9%-17.1% | 37.1%13.1% |
| 5 Year | n/a | 3.3%-3.7% | 75.9%37.1% |
Long-Term Price Volatility Vs. Market
How volatile is Terveystalo Oyj's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
Why Terveystalo Oyj (HEL:TTALO) Should Be In Your Dividend Portfolio2 months ago | Simply Wall St
Are Terveystalo Oyj's (HEL:TTALO) Statutory Earnings A Good Reflection Of Its Earnings Potential?2 months ago | Simply Wall St
Terveystalo Oyj Just Beat EPS By 30%: Here's What Analysts Think Will Happen NextValuation
Is Terveystalo Oyj undervalued compared to its fair value and its price relative to the market?
29.6%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TTALO (€10.46) is trading below our estimate of fair value (€14.91)
Significantly Below Fair Value: TTALO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TTALO is poor value based on its PE Ratio (34.3x) compared to the XE Healthcare industry average (26.7x).
PE vs Market: TTALO is poor value based on its PE Ratio (34.3x) compared to the Finnish market (26.4x).
Price to Earnings Growth Ratio
PEG Ratio: TTALO is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: TTALO is overvalued based on its PB Ratio (2.4x) compared to the XE Healthcare industry average (2x).
Next Steps
Future Growth
How is Terveystalo Oyj forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
20.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TTALO's forecast earnings growth (20.2% per year) is above the savings rate (0.3%).
Earnings vs Market: TTALO's earnings (20.2% per year) are forecast to grow faster than the Finnish market (15.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TTALO's revenue (4.9% per year) is forecast to grow faster than the Finnish market (4.2% per year).
High Growth Revenue: TTALO's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TTALO's Return on Equity is forecast to be low in 3 years time (12.6%).
Next Steps
Past Performance
How has Terveystalo Oyj performed over the past 5 years?
32.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TTALO has a large one-off loss of €17.7M impacting its September 30 2020 financial results.
Growing Profit Margin: TTALO's current net profit margins (4.1%) are lower than last year (5%).
Past Earnings Growth Analysis
Earnings Trend: TTALO has become profitable over the past 5 years, growing earnings by 32% per year.
Accelerating Growth: TTALO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TTALO had negative earnings growth (-17.8%) over the past year, making it difficult to compare to the Healthcare industry average (-0.3%).
Return on Equity
High ROE: TTALO's Return on Equity (7.2%) is considered low.
Next Steps
Financial Health
How is Terveystalo Oyj's financial position?
Financial Position Analysis
Short Term Liabilities: TTALO's short term assets (€172.2M) do not cover its short term liabilities (€291.3M).
Long Term Liabilities: TTALO's short term assets (€172.2M) do not cover its long term liabilities (€510.8M).
Debt to Equity History and Analysis
Debt Level: TTALO's debt to equity ratio (72.4%) is considered high.
Reducing Debt: TTALO's debt to equity ratio has reduced from 139.1% to 72.4% over the past 5 years.
Debt Coverage: TTALO's debt is well covered by operating cash flow (31.9%).
Interest Coverage: TTALO's interest payments on its debt are well covered by EBIT (8.7x coverage).
Balance Sheet
Next Steps
Dividend
What is Terveystalo Oyj current dividend yield, its reliability and sustainability?
1.24%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: TTALO's dividend (1.24%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (1.66%).
High Dividend: TTALO's dividend (1.24%) is low compared to the top 25% of dividend payers in the Finnish market (3.95%).
Stability and Growth of Payments
Stable Dividend: TTALO has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: TTALO's dividend payments have increased, but the company has only paid a dividend for 3 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (42.6%), TTALO's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: TTALO's dividends in 3 years are forecast to be well covered by earnings (42.8% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.9yrs
Average management tenure
CEO
Ville Iho (51 yo)
1.08yrs
Tenure
€27,273
Compensation
Mr. Ville Iho has been President & CEO of Terveystalo Oyj since December 6, 2019. Mr. Iho served as Chief Executive Officer at Nurminen Logistics Oyj since March 18, 2019 until December 05, 2019 and its Pr...
CEO Compensation Analysis
Compensation vs Market: Ville's total compensation ($USD32.99K) is below average for companies of similar size in the Finnish market ($USD940.00K).
Compensation vs Earnings: Insufficient data to compare Ville's compensation with company performance.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 1.08yrs | €27.27k | no data | |
| Chief Financial Officer | 6yrs | no data | 0.25% € 3.3m | |
| Director of Operations | 1yr | no data | no data | |
| Senior Vice President of Legal | 0.50yr | no data | no data | |
| Vice President of Communications | no data | no data | no data | |
| Senior Vice President of Consumer Business | 0.67yr | no data | no data | |
| Senior Vice President of Human Resources | 0.92yr | no data | no data | |
| Chief Digital Officer | 5yrs | no data | 0.070% € 925.6k | |
| Executive Officer | 5yrs | no data | no data | |
| Senior Vice President of Medical Clinic Network | 5yrs | no data | 0.040% € 528.8k | |
| Senior Vice President of Well-being | 5yrs | no data | 0.019% € 246.8k | |
| Chief Medical Officer | 1.92yrs | no data | no data |
1.9yrs
Average Tenure
45.5yo
Average Age
Experienced Management: TTALO's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 5yrs | €63.25k | 0.020% € 269.4k | |
| Independent Chairman of the Board | 1.75yrs | €91.31k | 0.0033% € 44.5k | |
| Independent Director | no data | €61.91k | 0.0086% € 114.4k | |
| Independent Director | 1.75yrs | €50.05k | 0.0013% € 17.7k | |
| Independent Vice-Chairman of the Board | 2.75yrs | €61.91k | 0.0031% € 41.1k | |
| Independent Director | 0.67yr | no data | no data | |
| Independent Director | 2.75yrs | €53.65k | 0.0025% € 32.8k |
2.3yrs
Average Tenure
55yo
Average Age
Experienced Board: TTALO's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Terveystalo Oyj's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Terveystalo Oyj
- Ticker: TTALO
- Exchange: HLSE
- Founded: 2001
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €1.332b
- Shares outstanding: 127.31m
- Website: https://www.terveystalo.com
Number of Employees
Location
- Terveystalo Oyj
- Jaakonkatu 3 B
- 3rd Floor
- Helsinki
- Uusimaa
- 100
- Finland
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| TTALO | HLSE (OMX Nordic Exchange Helsinki) | Yes | Common Shares | FI | EUR | Oct 2017 |
| 4TS | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Oct 2017 |
| 0RV1 | LSE (London Stock Exchange) | Yes | Common Shares | GB | EUR | Oct 2017 |
| TTAL.F | OTCPK (Pink Sheets LLC) | Yes | Common Shares | US | USD | Oct 2017 |
| TTALOH | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Shares | GB | EUR | Oct 2017 |
Biography
Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; a...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/22 18:43 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.